TCM Group A/S (OCSE:TCM)

kr 68.2 -0.4 (-0.58%) Market Cap: 712.05 Mil Enterprise Value: 997.05 Mil PE Ratio: 24.15 PB Ratio: 1.29 GF Score: 83/100

Q2 2024 TCM Group A/S Earnings Call Transcript
Aug 21, 2024

kr64.4 (+1.26%)

Earnings
Q1 2024 TCM Group A/S Earnings Call Transcript
May 16, 2024

kr57 (+8.37%)

Earnings
Q4 2023 TCM Group A/S Earnings Call Transcript
Feb 28, 2024

kr50.6 (+2.22%)

Earnings
TCM Group A/S Conference Call Transcript
Oct 19, 2023
Q2 2023 TCM Group A/S Earnings Call Transcript
Aug 18, 2023

kr62.2 (-3.42%)

Earnings
Q3 2022 TCM Group A/S Earnings Call Transcript
Nov 15, 2022

kr68.5 (-5.65%)

Earnings
Q2 2022 TCM Group A/S Earnings Call Transcript
Aug 19, 2022

kr85 (-5.56%)

Earnings
Q1 2022 TCM Group A/S Earnings Call Transcript
May 18, 2022

kr107 (+5.31%)

Earnings
Full Year 2021 TCM Group A/S Earnings Call Transcript
Feb 25, 2022

kr124 (+0.40%)

Earnings
Q3 2021 TCM Group A/S Earnings Call Transcript
Nov 12, 2021

kr158 (-3.07%)

Earnings
Q2 2021 TCM Group A/S Earnings Call Transcript
Aug 20, 2021

kr158 (+2.60%)

Earnings
Q1 2021 TCM Group A/S Earnings Call Transcript
May 19, 2021

kr164 (-4.93%)

Earnings
Q4 2020 TCM Group A/S Earnings Call Transcript
Feb 24, 2021

kr144.5 (-4.30%)

Earnings
Q3 2020 TCM Group A/S Earnings Call Transcript
Nov 11, 2020

kr128.5 (-4.46%)

Earnings
Q2 2020 Tcm Group A/S Earnings Call Transcript
Aug 18, 2020

kr129.5 (-5.47%)

Earnings
Q1 2020 Tcm Group A/S Earnings Call Transcript
May 06, 2020

kr94.6 (-1.87%)

Earnings
Q4 2019 Tcm Group A/S Earnings Call Transcript
Feb 26, 2020

kr125 (-8.76%)

Earnings
Q3 2019 Tcm Group A/S Earnings Call Transcript
Nov 06, 2019

kr112 (+0.90%)

Earnings
Q2 2019 Tcm Group A/S Earnings Call Transcript
Aug 14, 2019

kr112 (+1.36%)

Earnings
Q1 2019 Tcm Group A/S Earnings Call Transcript
May 07, 2019

kr110 (-1.35%)

Earnings

Q3 2019 Tcm Group A/S Earnings Call Transcript

Nov 06, 2019 / 08:30AM GMT

Release Date Price: kr112 (+0.90%)

Transcript

Ole Lund Andersen;S;CEO

TCM Group A

/-

Yes. Good morning, ladies and gentlemen. We have been looking forward to making presentation on our Q3 report for TCM.

And I will, together with our CFO, Mogens Elbrond Pedersen, comment on the business and financial results, after which we'll be handing over to the operator for a Q&A session.

So please turn to Page #2. Q3 was another strong quarter for TCM with a revenue growth of 17.3%, and this growth was entirely an organic growth. We are pleased to see that we continue to gain market share. Business-to-consumer is growing above market growth rates, and at the same time, business-to-business continued to have the highest growth rates. And we can see that our strategy of expanding across the business-to-business categories is successful.

Revenue for the quarter was DKK 238 million compared to DKK 202 million in Q3 last year. Adjusted EBITA increased by 19.9% to DKK 39 million, corresponding to an EBITA margin of 16.4%. This is slightly higher than the Q3 last year, which was at 16.1%. Our net working

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.